Company Filing History:
Years Active: 2024-2025
Title: Christopher J Borths: Innovator in Pharmaceutical Chemistry
Introduction
Christopher J Borths is a notable inventor based in Sherborn, MS (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds related to obicetrapib. With a total of 2 patents, his work is recognized for its innovative approaches to drug synthesis.
Latest Patents
Borths' latest patents focus on the "Salts of obicetrapib and processes for their manufacture and intermediates thereof." This patent outlines a method for manufacturing a compound of obicetrapib and its salts, including calcium salts. Additionally, it introduces amorphous obicetrapib hemicalcium and new intermediates for the synthesis of obicetrapib, such as obicetrapib HCl and a mesylate salt.
Career Highlights
Christopher J Borths is currently associated with NewAmsterdam Pharma B.V., where he continues to advance his research in pharmaceutical innovations. His expertise in the synthesis of complex compounds has positioned him as a valuable asset in the pharmaceutical industry.
Collaborations
Borths has collaborated with notable colleagues, including Sheng Cui and Andreas René Rötheli. These partnerships have fostered a collaborative environment that enhances the development of innovative pharmaceutical solutions.
Conclusion
Christopher J Borths exemplifies the spirit of innovation in pharmaceutical chemistry through his patents and collaborative efforts. His work continues to impact the field significantly, paving the way for future advancements in drug development.